Bronte Capital Management Pty Ltd.
Bronte Capital Management Pty Ltd. reported 58 holdings worth US$931M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 5, 2026
Bronte Capital Management Pty Ltd. reported 58 holdings worth US$931M as of Jun 30, 2026. Largest: Alphabet Inc (google) Class C, Regeneron Pharmaceuticals, Inc. and Interactive Brokers Group, Inc. Filed Aug 5, 2026 (Form 13F).
- Holdings
- 58
- Value as reported
- US$931M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Alphabet Inc (google) Class C | 305K | US$109M | 11.7% |
| Regeneron Pharmaceuticals, Inc. | 163K | US$101M | 10.9% |
| Interactive Brokers Group, Inc. | 884K | US$76.9M | 8.3% |
| Berkshire Hathaway Inc. | 146K | US$73M | 7.8% |
| Amazon.com, Inc. | 261K | US$62.3M | 6.7% |
| Philip Morris International Inc | 300K | US$54.3M | 5.8% |
| Corteva, Inc. | 457K | US$38.7M | 4.2% |
| Capital One Financial Corporation | 174K | US$34.8M | 3.7% |
| Walt Disney Company (the) | 360K | US$34.7M | 3.7% |
| First Citizens Bancshares, Inc. | 14,179 | US$29.5M | 3.2% |
| Bbb Foods Inc. | 533K | US$22.2M | 2.4% |
| Brown Forman Inc | 562K | US$15M | 1.6% |
| Aurora Innovation, Inc. | 2.19M | US$14.9M | 1.6% |
| Nektar Therapeutics | 198K | US$13.9M | 1.5% |
| Graham Holdings Company | 11,454 | US$13.1M | 1.4% |
| Alnylam Pharmaceuticals, Inc. | 35,384 | US$10.7M | 1.1% |
| Sociedad Quimica Y Minera De Chile Sa Pfd Series A | 116K | US$8.61M | 0.92% |
| Newmont Corporation | 69,494 | US$6.49M | 0.70% |
| Barrick Mining Corporation | 146K | US$5.38M | 0.58% |
| Liveramp Holdings, Inc. | 128K | US$4.83M | 0.52% |
| Herbalife Ltd. | 323K | US$4.25M | 0.46% |
| Revolution Medicines, Inc. | 18,780 | US$3.52M | 0.38% |
| Turning Point Brands, Inc. | 40,721 | US$3.45M | 0.37% |
| Bath & Body Works, Inc. | 144K | US$3.33M | 0.36% |
| Mondelez International, Inc. | 53,234 | US$3.08M | 0.33% |
| Tyler Technologies, Inc. | 8,302 | US$2.43M | 0.26% |
| Paylocity Holding Corporation | 17,874 | US$1.87M | 0.20% |
| Nice Ltd. | 16,396 | US$1.49M | 0.16% |
| Universal Display Corporation | 10,269 | US$889K | 0.10% |
| Verisk Analytics, Inc. | 2,682 | US$481K | 0.05% |
| Enovix Corporation | 41,765 | US$92,900 | <0.01% |
| Treace Medical Concepts, Inc. | 15,577 | US$61,996 | <0.01% |
| Fate Therapeutics, Inc. | 21,740 | US$58,698 | <0.01% |
| An2 Therapeutics, Inc. | 10,895 | US$52,732 | <0.01% |
| C4 Therapeutics, Inc. | 10,349 | US$48,330 | <0.01% |
| Alx Oncology Holdings Inc. | 18,095 | US$37,457 | <0.01% |
| Blend Labs, Inc. | 19,247 | US$32,912 | <0.01% |
| Pepgen Inc. | 17,776 | US$31,997 | <0.01% |
| Commerce.com, Inc. - Series 1 | 10,278 | US$30,423 | <0.01% |
| Pacific Biosciences Of California, Inc. | 17,881 | US$30,040 | <0.01% |
| Acumen Pharmaceuticals, Inc. | 10,716 | US$28,612 | <0.01% |
| Seer, Inc. | 15,109 | US$25,081 | <0.01% |
| Alector, Inc. | 11,758 | US$23,634 | <0.01% |
| Coherus Oncology, Inc. | 15,262 | US$21,367 | <0.01% |
| Milestone Pharmaceuticals Inc. | 14,390 | US$19,283 | <0.01% |
| Gossamer Bio, Inc. | 67,754 | US$11,152 | <0.01% |
| Rani Therapeutics Holdings, Inc. | 0 | US$0 | 0.00% |
| Sally Beauty Holdings, Inc. (name To Be Changed From Sally Holdings, Inc.) | 0 | US$0 | 0.00% |
| Caribou Biosciences, Inc. | 0 | US$0 | 0.00% |
| Fractyl Health, Inc. | 0 | US$0 | 0.00% |
| Invivyd, Inc. | 0 | US$0 | 0.00% |
| James River Group Holdings, Inc. | 0 | US$0 | 0.00% |
| Pinterest, Inc. | 0 | US$0 | 0.00% |
| Pliant Therapeutics, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related